The role of angiotensin type 1 receptor in inflammation and endothelial dysfunction.
Endothelial dysfunction plays an important role in all stages of atherosclerosis, and is characterized by an increased activity of vasoconstricting factors, proinflammatory and prothrombotic mediators. The aim of the review is to evaluate the role of angiotensin II (Ang II) and especially of angiotensin type 1 (AT1) receptor in inflammation and endothelial dysfunction. Ang II with AT(1) receptor are through several mechanisms implicated in the progression of atherosclerosis. Stimulation of AT(1) receptor increases oxidative stress especially through activation of NADH/NADPH oxidase in the vascular cells. Oxidative stress is associated with activation of the inflammatory processes. Ang II via AT(1) receptor increases expression of adhesion molecules and stimulates the induction of monocyte chemoattractant protein-1 (MCP-1). AT(1) receptor enhances the activation of nuclear factor NF-kappaB, which stimulates the production of proinflammatory cytokines. Proinflammatory cytokines on the other side may induce acute-phase response in the liver. Activation of AT(1) receptor via inducible cyclooxygenase (COX)-2 promotes biosynthesis of matrix metalloproteinases (MMPs). Ang II is implicated in the process of angiogenesis. Via AT(1) receptor takes part in the regulation of vascular endothelial growth factor (VEGF), which is one of the most angiogenic factors and stimulates the activity of endothelial progenitor cells (EPC). Recently some patents were reported discussing role of different compounds for the treatment of cardiovascular disease, renovascular disease nephropathy, peripheral vascular disease, portal hypertension and ophthalmic disorders, are cyclooxygenase-2 inhibitors.
Skultetyova
Dana
D
Department Cardiology, National Institute of Cardiovascular Diseases, Bratislava, Slovak Republic. skultety@nusch.sk
Filipova
Slavomira
S
Riecansky
Igor
I
Skultety
Jan
J
D000818:Animals; D042783:Endothelial Cells / Q000502:physiology*; D005342:Fibrinolysis; D006801:Humans; D007249:Inflammation / Q000209:etiology*; D018384:Oxidative Stress; D044140:Receptor, Angiotensin, Type 1 / Q000502:physiology*; D042461:Vascular Endothelial Growth Factor A / Q000502:physiology
D044140:Receptor, Angiotensin, Type 1; D042461:Vascular Endothelial Growth Factor A